Avanos Medical, Inc.AVNSNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-8.9%
5Y CAGR-7.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-8.9%/yr
vs -7.5%/yr prior
5Y CAGR
-7.9%/yr
Consistent
Acceleration
-1.4pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.7x
Contraction
Streak
7 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $23.10M | -11.8% |
| 2024 | $26.20M | -3.7% |
| 2023 | $27.20M | -11.1% |
| 2022 | $30.60M | -5.3% |
| 2021 | $32.30M | -7.4% |
| 2020 | $34.90M | -7.4% |
| 2019 | $37.70M | -9.8% |
| 2018 | $41.80M | +9.4% |
| 2017 | $38.20M | -0.5% |
| 2016 | $38.40M | - |